CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity
Chunying Liu(Medical College of Wisconsin), Joseph C. Wu(Cardiovascular Institute of the South)
Cited by 35
Related Papers
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
|Nature Reviews Cardiology|2020|1.5k
Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes
|Cell stem cell|2020|232
Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome
|Cell stem cell|2020|171